Login / Signup

Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study.

Yongjian GuoJingqiang WuLicong LiangKangshun ZhuJingwen ZhouLiteng LinYe ChenBihui CaoMingji HeHui LianWensou HuangMingyue Cai
Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)
TKI-I was safe and significantly improved survival over TKI alone in HCC patients with TACE refractoriness.
Keyphrases
  • tyrosine kinase
  • advanced non small cell lung cancer
  • high dose
  • radiofrequency ablation
  • radiation therapy
  • chronic myeloid leukemia
  • magnetic resonance
  • low dose
  • liver metastases